GRAIL (NASDAQ:GRAL) CEO Sells $498,622.32 in Stock

Key Points

• GRAIL CEO Robert Ragusa sold 7,239 shares of the company's stock for approximately $498,622 on October 15, reducing his ownership by 0.99% to 727,388 shares.
• GRAIL's stock price rose by 14.4%, reaching $86.41 with a market capitalization of $3.11 billion.
• The company reported a loss of $3.18 earnings per share for the last quarter, falling short of analysts' expectations and experiencing a negative net margin of 329.86%.

GRAIL, Inc. (NASDAQ:GRAL - Get Free Report) CEO Robert Ragusa sold 7,239 shares of the firm's stock in a transaction dated Wednesday, October 15th. The shares were sold at an average price of $68.88, for a total value of $498,622.32. Following the transaction, the chief executive officer owned 727,388 shares of the company's stock, valued at $50,102,485.44. This trade represents a 0.99% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

GRAIL Stock Up 14.4%

NASDAQ:GRAL traded up $10.89 on Thursday, reaching $86.41. 2,082,810 shares of the company's stock were exchanged, compared to its average volume of 1,271,702. The firm has a market capitalization of $3.11 billion, a price-to-earnings ratio of -6.59 and a beta of 4.11. GRAIL, Inc. has a 52-week low of $12.76 and a 52-week high of $89.57. The business has a fifty day moving average of $44.22 and a 200-day moving average of $39.30.

GRAIL (NASDAQ:GRAL - Get Free Report) last announced its quarterly earnings data on Tuesday, August 12th. The company reported ($3.18) earnings per share for the quarter, missing analysts' consensus estimates of ($3.14) by ($0.04). The business had revenue of $35.54 million during the quarter, compared to analyst estimates of $37.57 million. GRAIL had a negative net margin of 329.86% and a negative return on equity of 16.64%. As a group, equities analysts anticipate that GRAIL, Inc. will post -15.15 earnings per share for the current year.

Wall Street Analysts Forecast Growth

GRAL has been the topic of several analyst reports. Canaccord Genuity Group increased their price objective on GRAIL from $43.00 to $75.00 and gave the company a "buy" rating in a research note on Friday, October 3rd. Weiss Ratings reaffirmed a "sell (d-)" rating on shares of GRAIL in a research report on Wednesday, October 8th. Finally, UBS Group set a $75.00 price objective on GRAIL in a research note on Friday, October 3rd. One research analyst has rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and an average price target of $56.67.

Institutional Trading of GRAIL

Hedge funds and other institutional investors have recently bought and sold shares of the business. Teacher Retirement System of Texas lifted its holdings in GRAIL by 5.5% during the 2nd quarter. Teacher Retirement System of Texas now owns 8,538 shares of the company's stock worth $439,000 after buying an additional 447 shares during the last quarter. Parallel Advisors LLC lifted its stake in GRAIL by 24.1% during the second quarter. Parallel Advisors LLC now owns 2,313 shares of the company's stock worth $119,000 after purchasing an additional 449 shares during the last quarter. S.A. Mason LLC lifted its position in shares of GRAIL by 50.1% during the 1st quarter. S.A. Mason LLC now owns 1,499 shares of the company's stock worth $38,000 after buying an additional 500 shares during the last quarter. Crown Wealth Group LLC raised its stake in GRAIL by 5.9% during the 2nd quarter. Crown Wealth Group LLC now owns 8,986 shares of the company's stock worth $462,000 after acquiring an additional 500 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in GRAIL by 28.2% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,835 shares of the company's stock valued at $76,000 after acquiring an additional 623 shares in the last quarter.

GRAIL Company Profile

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.